Motesanib Diphosphate (AMG 706), an Oral Angiogenesis Inhibitor, Demonstrates Clinical Efficacy in Advanced Thymoma

Acta Oncologica - United Kingdom
doi 10.1080/02841860802495362
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Motesanib Diphosphate in Progressive Differentiated Thyroid Cancer

New England Journal of Medicine
Medicine
2008English

A Selective FLT3 Inhibitor Shows Clinical Efficacy in AML

Cancer Discovery
Oncology
2013English

LB780 Randomized, Blind, Placebo-Controlled Clinical Trial on the Clinical Efficacy of Oclacitinib, an Oral Janus Kinase Inhibitor, in a Canine Model of Spontaneously Occurring Atopic Dermatitis

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2016English

Targeting Angiogenesis in Advanced Cervical Cancer

Therapeutic Advances in Medical Oncology
Oncology
2014English

Minimally Invasive Thymectomy for Locally Advanced Recurrent Thymoma

Journal of Visualized Surgery
2016English

First-In-Human Phase I Study of an Oral HSP90 Inhibitor, TAS-116, in Patients With Advanced Solid Tumors

Molecular Cancer Therapeutics
Cancer ResearchOncology
2019English

Efficacy of the Oral mTORC1 Inhibitor Everolimus in Relapsed or Refractory Indolent Lymphoma

American Journal of Hematology
Hematology
2017English

Donepezil, an Acetylcholinesterase Inhibitor Against Alzheimer's Dementia, Promotes Angiogenesis in an Ischemic Hindlimb Model

Journal of Molecular and Cellular Cardiology
Cardiovascular MedicineMolecular BiologyCardiology
2010English

Inhibition of Angiogenesis by Erbstatin, an Inhibitor of Tyrosine Kinase.

Journal of Antibiotics
Drug DiscoveryPharmacology
1993English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy